LON:AZN - AstraZeneca Stock Price, News & Analysis

AstraZeneca trades on the London Stock Exchange (LON) under the ticker symbol "AZN."

AstraZeneca declared a dividend on Thursday, July 25th. Stockholders of record on Thursday, August 8th will be paid a dividend of GBX 71.90 per share on Monday, September 9th. This represents a dividend yield of 1.07%. The ex-dividend date is Thursday, August 8th. The official announcement can be seen at this link. View AstraZeneca's Dividend History.

AstraZeneca is scheduled to release their next quarterly earnings announcement on Thursday, October 24th 2019. View Earnings Estimates for AstraZeneca.

19 equities research analysts have issued twelve-month price targets for AstraZeneca's shares. Their forecasts range from GBX 5,180 to GBX 8,500. On average, they anticipate AstraZeneca's stock price to reach GBX 6,688.24 in the next year. This suggests that the stock has a possible downside of 9.4%. View Analyst Price Targets for AstraZeneca.

19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AstraZeneca in the last year. There are currently 3 sell ratings, 6 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for AstraZeneca.

News coverage about AZN stock has trended positive on Friday, InfoTrie Sentiment reports. The research firm identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. AstraZeneca earned a news sentiment score of 2.5 on InfoTrie's scale. They also assigned news headlines about the biopharmaceutical company a news buzz of 6.0 out of 10, meaning that recent press coverage is somewhat likely to have an impact on the company's share price in the next few days. View News Stories for AstraZeneca.

Some companies that are related to AstraZeneca include GlaxoSmithKline (GSK), Bayer (BAYN), Dechra Pharmaceuticals (DPH), Hutchison China MediTech (HCM), Mayne Pharma Group (MYX), Opthea (OPT), Vectura Group (VEC), Medical Developments International (MVP), Eco Animal Health Group (EAH), BEXIMCO PHARMAC/S GDR REGS (BXP), Trilogy International Partners (TRL), Futura Medical (FUM), Pharmaxis (PXS), Allergy Therapeutics (AGY) and Vita Life Sciences (VLS).

Based on aggregate information from My MarketBeat watchlists, some companies that other AstraZeneca investors own include GlaxoSmithKline (GSK), Vodafone Group (VOD), Hain Celestial Group (HAIN), National Retail Properties (NNN), NVIDIA (NVDA), BP (BP), Marks and Spencer Group (MKS), Encana (ECA), Philip Morris International (PM) and Anglo American (AAL).

Shares of AZN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

One share of AZN stock can currently be purchased for approximately GBX 7,384.

AstraZeneca has a market capitalization of £96.87 billion and generates £23.07 billion in revenue each year. AstraZeneca employs 64,400 workers across the globe.View Additional Information About AstraZeneca.

The official website for AstraZeneca is http://www.astrazeneca.com/.

AstraZeneca's mailing address is 1 Francis Crick Avenue Cambridge Biomedical Campus, CAMBRIDGE, CB2 0AA, United Kingdom. The biopharmaceutical company can be reached via phone at +44-20-73045000.